Mass Spectrometry‐Based Proteomics for Assessing Epitranscriptomic Regulations
Mass Spectrometry Reviews · 2026-07 · 45 (4) · 672-690
DOI: 10.1002/mas.21911 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Mass Spectrometry Reviews, online erschienen am 18.10.2024. Verfasst von Yen-Yu Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of California, Riverside, California, USA. Hauptthemen laut MEDLINE: Proteomics, Mass Spectrometry. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, This study was supported by National Institutes of Health, Grant/Award Number: R35 ES031707., National Institutes of Health.
Abstract (Originalsprache)
Epitranscriptomics is a rapidly evolving field that explores chemical modifications in RNA and how they contribute to dynamic and reversible regulations of gene expression. These modifications, for example, N 6 ‐methyladenosine (m 6 A), are crucial in various RNA metabolic processes, including splicing, stability, subcellular localization, and translation efficiency of mRNAs. Mass spectrometry‐based proteomics has become an indispensable tool in unraveling the complexities of epitranscriptomics, offering high‐throughput, precise protein identification, and accurate quantification of differential protein expression. Over the past two decades, advances in mass spectrometry, including the improvement of high‐resolution mass spectrometers and innovative sample preparation methods, have allowed researchers to perform in‐depth analyses of epitranscriptomic regulations. This review focuses on the applications of bottom‐up proteomics in the field of epitranscriptomics, particularly in identifying and quantifying epitranscriptomic reader, writer, and eraser (RWE) proteins and in characterizing their functions, posttranslational modifications, and interactions with other proteins. Together, by leveraging modern proteomics, researchers can gain deep insights into the intricate regulatory networks of RNA modifications, advancing fundamental biology, and fostering potential therapeutic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of California, Riverside, California, USA.
- Environmental Toxicology Graduate Program, University of California, Riverside, California, USA.
Förderung
- NIEHS NIH HHS
- This study was supported by National Institutes of Health, Grant/Award Number: R35 ES031707.
- National Institutes of Health
Zitieren
APA
Yang, Y. Y., Cao, Z., & Wang, Y. (2026). Mass Spectrometry‐Based Proteomics for Assessing Epitranscriptomic Regulations. Mass Spectrometry Reviews, 45(4), 672-690. https://doi.org/10.1002/mas.21911
Vancouver
Yang YY, Cao Z, Wang Y. Mass Spectrometry‐Based Proteomics for Assessing Epitranscriptomic Regulations. Mass Spectrometry Reviews. 2026;45(4):672-690. doi:10.1002/mas.21911
BibTeX
@article{Yang2026,
author = {Yang, Yen-Yu and Cao, Zhongwen and Wang, Yinsheng},
title = {Mass Spectrometry‐Based Proteomics for Assessing Epitranscriptomic Regulations},
journal = {Mass Spectrometry Reviews},
year = {2026},
volume = {45},
number = {4},
pages = {672--690},
doi = {10.1002/mas.21911}
}
EUVIMED